These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 6002159)
1. [Toward the study of the problem of the carcinogenic activity of medicinal preparations]. Naialkov NP; Shabad LM Vopr Onkol; 1966; 12(10):3-8. PubMed ID: 6002159 [No Abstract] [Full Text] [Related]
2. Risk assessment based upon mechanistic information: application to pharmaceuticals. Williams GM Prev Med; 1996; 25(1):23. PubMed ID: 8778754 [No Abstract] [Full Text] [Related]
3. [Apropos of the article: "Cost of studies on the carcinogenic effects of chemical compounds in animal experiments"]. Kosoĭ GKh Vopr Onkol; 1988; 34(2):240-1. PubMed ID: 3348016 [No Abstract] [Full Text] [Related]
6. Lifestyle-related factors and environmental agents causing cancer: an overview. Irigaray P; Newby JA; Clapp R; Hardell L; Howard V; Montagnier L; Epstein S; Belpomme D Biomed Pharmacother; 2007 Dec; 61(10):640-58. PubMed ID: 18055160 [TBL] [Abstract][Full Text] [Related]
7. Studies on mutagenic and carcinogenic N-substituted aryl compounds: cosmetics and drugs. Dybing E; Saxholm HJ; Aune T; Wirth PJ; Thorgeirsson SS Natl Cancer Inst Monogr; 1981 Dec; (58):21-26. PubMed ID: 7043276 [TBL] [Abstract][Full Text] [Related]
8. [Carcinogens in pharmacy and in the laboratory of analytical chemistry]. Reith JF Pharm Weekbl; 1972 Sep; 107(37):581-97. PubMed ID: 4653228 [No Abstract] [Full Text] [Related]
9. [The role of genetically determined acetylation of drugs and xenobiotics in pathogenesis of neoplastic diseases]. Niewiński P; Orzechowska-Juzwenko K Postepy Hig Med Dosw; 1996; 50(2):131-43. PubMed ID: 8848422 [TBL] [Abstract][Full Text] [Related]
10. Screening for possible drug carcinogenicity: second report of findings. Friedman GD; Ury HK J Natl Cancer Inst; 1983 Dec; 71(6):1165-75. PubMed ID: 6581357 [TBL] [Abstract][Full Text] [Related]
11. Epidemiological evidence relating to the possible carcinogenic effects of hair dyes in hairdressers and users of hair dyes. IARC Monogr Eval Carcinog Risk Chem Hum; 1982 Apr; 27():307-18. PubMed ID: 6955267 [No Abstract] [Full Text] [Related]
12. A new series of review articles on drug metabolizing enzymes: nomenclature of isoenzyme families, genetic organization, polymorphisms, substrate specificities, clinical relevance and role in carcinogenesis. Bolt HM; Hengstler JG Arch Toxicol; 2008 Jul; 82(7):413-4. PubMed ID: 18528684 [No Abstract] [Full Text] [Related]
14. [Clinical epidemiology--the risk of impairment]. Janout V; Janoutová G Cas Lek Cesk; 2004; 143(8):565-7. PubMed ID: 15446465 [TBL] [Abstract][Full Text] [Related]
15. [Significance of mutagenicity tests on safety evaluation of medicinal drugs]. Sofuni T Eisei Shikenjo Hokoku; 1993; (111):149-50. PubMed ID: 7920563 [TBL] [Abstract][Full Text] [Related]
16. Editorial overview: safety/toxicity threshold concepts in drug discovery and development. Johnson DE; Smith DA; Park BK Curr Opin Drug Discov Devel; 2005 Jan; 8(1):24-6. PubMed ID: 15679167 [No Abstract] [Full Text] [Related]
17. Drugs and herbal preparations: how safe are they? Vesselago M Can Fam Physician; 1997 Jun; 43():1047. PubMed ID: 9189286 [No Abstract] [Full Text] [Related]
18. Environmental and chemical carcinogenesis. Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140 [TBL] [Abstract][Full Text] [Related]
19. [Side-effects as a limit of modern medicinal therapy]. ESSELLIER AE Praxis; 1957 Jun; 46(26):570-5. PubMed ID: 13453136 [No Abstract] [Full Text] [Related]
20. [Dyskinesias and functional gastrointestinal disorders of medicinal origin]. Justin-Besançon L Acquis Med Recent; 1965; ():15-25. PubMed ID: 5838859 [No Abstract] [Full Text] [Related] [Next] [New Search]